Eli Lilly and Co. and its peers might be back in Congress’ sights as lawmakers hunt for more ways to cut health care
costs. A new study in the influential Health Affairs journal concludes that European drugmakers operating
in markets with pharmaceutical price controls have produced proportionally more innovations than their U.S. counterparts.
Indianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
Eli Lilly and Co. paid doctors in South Carolina for participating in a speakers’ program in exchange for prescribing the
antipsychotic Zyprexa, according to notes by Lilly sales representatives reviewed by Bloomberg News.
Pfizer Inc., the world’s largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription
drug promotions, the Justice Department announced today.
Locally based venture capital firms Cardinal Equity Partners and Centerfield Capital Partners have joined with Chicago-based
bank Harris NA to recapitalize the state’s largest independent physical therapy provider.
Bloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
Arcadia Resources Inc. narrowed its losses in its most recent quarter as it started to accelerate sales in its highly-touted
DailyMed program, the company said today.
The Indianapolis-based forensics, clinical and pharmaceutical testing firm now ranks 598, up from 1,466 a year ago. The list
is based on percentage of revenue growth.
It’s no secret that Eli Lilly and Co. is the biggest private employer in the Indianapolis area. But
Lilly also supplemented the incomes of a few dozen local doctors — to the tune of more than $224,000 in just the first
quarter.
The Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
Investors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
An exaggerated share of the nation’s wealth is paid to CEOs of public companies, their minions and directors, through agreements
made inside boardrooms, by highly compensated individuals who commit shareholders’ money and are not subject to effective
oversight.
In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers.
Rating doctors via online services helps consumers make better health care decisions.
As health care slowly shifts to operate more like retail stores, patients’ opinions of doctors have become commonplace on more than 30 physician-rating Web sites, including a subscription service run by Indianapolis-based Angie’s List.
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009
Small Business of the Year.
Catheter Research Inc. now is flying high—even in the midst of a bad economy.
Indianapolis-based medical-device startup NICO Corp. has raised $1.73 million from investors.
